1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meningococcal Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Meningococcal Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Menactra
1.4.3 Menomune
1.5 Market by Application
1.5.1 Global Meningococcal Vaccines Market Share by Application: 2021-2026
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Meningococcal Vaccines Market
1.8.1 Global Meningococcal Vaccines Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Meningococcal Vaccines Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Meningococcal Vaccines Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Meningococcal Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Meningococcal Vaccines Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Meningococcal Vaccines Sales Volume Market Share by Region (2015-2020)
3.2 Global Meningococcal Vaccines Sales Revenue Market Share by Region (2015-2020)
3.3 North America Meningococcal Vaccines Sales Volume
3.3.1 North America Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.3.2 North America Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Meningococcal Vaccines Sales Volume
3.4.1 East Asia Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Meningococcal Vaccines Sales Volume (2015-2020)
3.5.1 Europe Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Meningococcal Vaccines Sales Volume (2015-2020)
3.6.1 South Asia Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Meningococcal Vaccines Sales Volume (2015-2020)
3.7.1 Southeast Asia Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Meningococcal Vaccines Sales Volume (2015-2020)
3.8.1 Middle East Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Meningococcal Vaccines Sales Volume (2015-2020)
3.9.1 Africa Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Meningococcal Vaccines Sales Volume (2015-2020)
3.10.1 Oceania Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Meningococcal Vaccines Sales Volume (2015-2020)
3.11.1 South America Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.11.2 South America Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Meningococcal Vaccines Sales Volume (2015-2020)
3.12.1 Rest of the World Meningococcal Vaccines Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Meningococcal Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Meningococcal Vaccines Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Meningococcal Vaccines Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Meningococcal Vaccines Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Meningococcal Vaccines Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Meningococcal Vaccines Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Meningococcal Vaccines Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Meningococcal Vaccines Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Meningococcal Vaccines Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Meningococcal Vaccines Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Meningococcal Vaccines Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Meningococcal Vaccines Sales Volume Market Share by Type (2015-2020)
14.2 Global Meningococcal Vaccines Sales Revenue Market Share by Type (2015-2020)
14.3 Global Meningococcal Vaccines Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Meningococcal Vaccines Consumption Volume by Application (2015-2020)
15.2 Global Meningococcal Vaccines Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Meningococcal Vaccines Business
16.1 GlaxoSmithKline
16.1.1 GlaxoSmithKline Company Profile
16.1.2 GlaxoSmithKline Meningococcal Vaccines Product Specification
16.1.3 GlaxoSmithKline Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Sanofi
16.2.1 Sanofi Company Profile
16.2.2 Sanofi Meningococcal Vaccines Product Specification
16.2.3 Sanofi Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 JN-International Medical
16.3.1 JN-International Medical Company Profile
16.3.2 JN-International Medical Meningococcal Vaccines Product Specification
16.3.3 JN-International Medical Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novartis International
16.4.1 Novartis International Company Profile
16.4.2 Novartis International Meningococcal Vaccines Product Specification
16.4.3 Novartis International Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Baxter International
16.5.1 Baxter International Company Profile
16.5.2 Baxter International Meningococcal Vaccines Product Specification
16.5.3 Baxter International Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Pfizer
16.6.1 Pfizer Company Profile
16.6.2 Pfizer Meningococcal Vaccines Product Specification
16.6.3 Pfizer Meningococcal Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Meningococcal Vaccines Manufacturing Cost Analysis
17.1 Meningococcal Vaccines Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Meningococcal Vaccines
17.4 Meningococcal Vaccines Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Meningococcal Vaccines Distributors List
18.3 Meningococcal Vaccines Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Meningococcal Vaccines (2021-2026)
20.2 Global Forecasted Revenue of Meningococcal Vaccines (2021-2026)
20.3 Global Forecasted Price of Meningococcal Vaccines (2015-2026)
20.4 Global Forecasted Production of Meningococcal Vaccines by Region (2021-2026)
20.4.1 North America Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.3 Europe Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.7 Africa Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.9 South America Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Meningococcal Vaccines Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Meningococcal Vaccines by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Meningococcal Vaccines by Country
21.2 East Asia Market Forecasted Consumption of Meningococcal Vaccines by Country
21.3 Europe Market Forecasted Consumption of Meningococcal Vaccines by Countriy
21.4 South Asia Forecasted Consumption of Meningococcal Vaccines by Country
21.5 Southeast Asia Forecasted Consumption of Meningococcal Vaccines by Country
21.6 Middle East Forecasted Consumption of Meningococcal Vaccines by Country
21.7 Africa Forecasted Consumption of Meningococcal Vaccines by Country
21.8 Oceania Forecasted Consumption of Meningococcal Vaccines by Country
21.9 South America Forecasted Consumption of Meningococcal Vaccines by Country
21.10 Rest of the world Forecasted Consumption of Meningococcal Vaccines by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer